Evotec SE (EVO) Dividends Paid - Common Growth (1y) (2010 - 2026)
Evotec SE (EVO) Dividends Paid - Common Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.78 Bn | 42.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.42 Bn | 29.74 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.53 Bn | 22.73 Bn | 5.10 Bn | 6.20% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | 51.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.29% |
| Sep 30, 2025 | -1,101.22% |
| Jun 30, 2025 | 91.06% |
| Mar 31, 2025 | -35.49% |
| Sep 30, 2024 | -76.02% |
| Jun 30, 2024 | -535.94% |
| Mar 31, 2024 | 4.98% |
| Sep 30, 2023 | 118.35% |
| Jun 30, 2023 | 30.91% |
| Mar 31, 2023 | -40.21% |
| Sep 30, 2022 | -307.47% |
| Jun 30, 2022 | 267.71% |
| Mar 31, 2022 | 53.03% |
| Jun 30, 2010 | -18.71% |
| Mar 31, 2010 | -37.71% |